These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 18463625)
21. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling. Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496 [TBL] [Abstract][Full Text] [Related]
22. [Update on propofol TCI in children]. Constant I; Rigouzzo A; Louvet N Ann Fr Anesth Reanim; 2013 Jan; 32(1):e37-42. PubMed ID: 23219572 [TBL] [Abstract][Full Text] [Related]
23. A step towards effect-site target-controlled infusion with propofol in dogs: a k(e0) for propofol. Brás S; Bressan N; Ribeiro L; Ferreira DA; Antunes L; Nunes CS J Vet Pharmacol Ther; 2009 Apr; 32(2):182-8. PubMed ID: 19290949 [TBL] [Abstract][Full Text] [Related]
28. On the use of multivariable piecewise-linear models for predicting human response to anesthesia. Lin HH; Beck CL; Bloom MJ IEEE Trans Biomed Eng; 2004 Nov; 51(11):1876-87. PubMed ID: 15536890 [TBL] [Abstract][Full Text] [Related]
29. PK-PD modeling of protein drugs: implications in assay development. Roskos LK; Schneider A; Vainshtein I; Schwickart M; Lee R; Lu H; Faggioni R; Liang M Bioanalysis; 2011 Mar; 3(6):659-75. PubMed ID: 21417734 [TBL] [Abstract][Full Text] [Related]
30. The effect of altered physiological states on intravenous anesthetics. Henthorn TK Handb Exp Pharmacol; 2008; (182):363-77. PubMed ID: 18175100 [TBL] [Abstract][Full Text] [Related]
31. No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients. La Colla L; Albertin A; La Colla G; Ceriani V; Lodi T; Porta A; Aldegheri G; Mangano A; Khairallah I; Fermo I Eur J Anaesthesiol; 2009 May; 26(5):362-9. PubMed ID: 19307972 [TBL] [Abstract][Full Text] [Related]
32. [Fundamental and clinical studies on intravenous anesthesia]. Kazama T Masui; 2001 Dec; 50 Suppl():S82-8. PubMed ID: 11871108 [No Abstract] [Full Text] [Related]
33. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics. Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331 [TBL] [Abstract][Full Text] [Related]
34. Population pharmacodynamic and pharmacokinetic modeling via mixed effects. Piotrovsky VK Curr Opin Drug Discov Devel; 2000 May; 3(3):314-30. PubMed ID: 19649865 [TBL] [Abstract][Full Text] [Related]
35. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid. Delavenne X; Laporte S; Demasles S; Mallouk N; Basset T; Tod M; Girard P; Mismetti P Fundam Clin Pharmacol; 2009 Feb; 23(1):127-35. PubMed ID: 19267776 [TBL] [Abstract][Full Text] [Related]
37. Prospective evaluation of the time to peak effect of propofol to target the effect site in children. Muñoz HR; León PJ; Fuentes RS; Echevarría GC; Cortínez LI Acta Anaesthesiol Scand; 2009 Aug; 53(7):883-90. PubMed ID: 19496767 [TBL] [Abstract][Full Text] [Related]
38. Circadian rhythms and their development in children: implications for pharmacokinetics and pharmacodynamics in anesthesia. Potts AL; Cheeseman JF; Warman GR Paediatr Anaesth; 2011 Mar; 21(3):238-46. PubMed ID: 20561229 [TBL] [Abstract][Full Text] [Related]
39. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses. Whittem T; Pasloske KS; Heit MC; Ranasinghe MG J Vet Pharmacol Ther; 2008 Dec; 31(6):571-9. PubMed ID: 19000281 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery. Foster D; Upton R; Christrup L; Popper L Ann Pharmacother; 2008 Oct; 42(10):1380-7. PubMed ID: 18728103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]